These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 16412651)

  • 21. Highly selective aldose reductase inhibitors. 3. Structural diversity of 3-(arylmethyl)-2,4,5-trioxoimidazolidine-1-acetic acids.
    Kotani T; Nagaki Y; Ishii A; Konishi Y; Yago H; Suehiro S; Okukado N; Okamoto K
    J Med Chem; 1997 Feb; 40(5):684-94. PubMed ID: 9057855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Artificial neural networks-based approach to design ARIs using QSAR for diabetes mellitus.
    Patra JC; Singh O
    J Comput Chem; 2009 Nov; 30(15):2494-508. PubMed ID: 19373836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Curcumin analogs as potent aldose reductase inhibitors.
    Du ZY; Bao YD; Liu Z; Qiao W; Ma L; Huang ZS; Gu LQ; Chan AS
    Arch Pharm (Weinheim); 2006 Mar; 339(3):123-8. PubMed ID: 16528793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aldose reductase inhibitory effect by tectorigenin derivatives from Viola hondoensis.
    Moon HI; Jung JC; Lee J
    Bioorg Med Chem; 2006 Nov; 14(22):7592-4. PubMed ID: 16870454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 1-Benzopyran-4-one antioxidants as aldose reductase inhibitors.
    Costantino L; Rastelli G; Gamberini MC; Vinson JA; Bose P; Iannone A; Staffieri M; Antolini L; Del Corso A; Mura U; Albasini A
    J Med Chem; 1999 Jun; 42(11):1881-93. PubMed ID: 10354396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. QSAR prediction of inhibition of aldose reductase for flavonoids.
    Mercader AG; Duchowicz PR; Fernández FM; Castro EA; Bennardi DO; Autino JC; Romanelli GP
    Bioorg Med Chem; 2008 Aug; 16(15):7470-6. PubMed ID: 18585047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carboxymethylated pyridoindole antioxidants as aldose reductase inhibitors: Synthesis, activity, partitioning, and molecular modeling.
    Stefek M; Snirc V; Djoubissie PO; Majekova M; Demopoulos V; Rackova L; Bezakova Z; Karasu C; Carbone V; El-Kabbani O
    Bioorg Med Chem; 2008 May; 16(9):4908-20. PubMed ID: 18395454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-activity relationships and molecular modelling of 5-arylidene-2,4-thiazolidinediones active as aldose reductase inhibitors.
    Maccari R; Ottanà R; Curinga C; Vigorita MG; Rakowitz D; Steindl T; Langer T
    Bioorg Med Chem; 2005 Apr; 13(8):2809-23. PubMed ID: 15781392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro evaluation of 5-arylidene-2-thioxo-4-thiazolidinones active as aldose reductase inhibitors.
    Maccari R; Del Corso A; Giglio M; Moschini R; Mura U; Ottanà R
    Bioorg Med Chem Lett; 2011 Jan; 21(1):200-3. PubMed ID: 21129963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationships between structure and high-throughput screening permeability of diverse drugs with artificial membranes: application to prediction of Caco-2 cell permeability.
    Fujikawa M; Ano R; Nakao K; Shimizu R; Akamatsu M
    Bioorg Med Chem; 2005 Aug; 13(15):4721-32. PubMed ID: 15936203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rational design of an indolebutanoic acid derivative as a novel aldose reductase inhibitor based on docking and 3D QSAR studies of phenethylamine derivatives.
    Sun WS; Park YS; Yoo J; Park KD; Kim SH; Kim JH; Park HJ
    J Med Chem; 2003 Dec; 46(26):5619-27. PubMed ID: 14667216
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative structure-activity analysis of 5-arylidene-2,4-thiazolidinediones as aldose reductase inhibitors.
    Sambasivarao SV; Soni LK; Gupta AK; Hanumantharao P; Kaskhedikar SG
    Bioorg Med Chem Lett; 2006 Feb; 16(3):512-20. PubMed ID: 16297625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis, activity, and molecular modeling of a new series of tricyclic pyridazinones as selective aldose reductase inhibitors.
    Costantino L; Rastelli G; Vescovini K; Cignarella G; Vianello P; Del Corso A; Cappiello M; Mura U; Barlocco D
    J Med Chem; 1996 Oct; 39(22):4396-405. PubMed ID: 8893834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and aldose reductase inhibitory activities of novel O-substituted hydroxyphenylacetic acid derivatives.
    Rakowitz D; Angerer H; Matuszczak B
    Arch Pharm (Weinheim); 2006 Oct; 339(10):547-58. PubMed ID: 17009299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and synthesis of highly potent and selective (2-arylcarbamoyl-phenoxy)-acetic acid inhibitors of aldose reductase for treatment of chronic diabetic complications.
    Van Zandt MC; Sibley EO; McCann EE; Combs KJ; Flam B; Sawicki DR; Sabetta A; Carrington A; Sredy J; Howard E; Mitschler A; Podjarny AD
    Bioorg Med Chem; 2004 Nov; 12(21):5661-75. PubMed ID: 15465344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, activity, and molecular modeling studies of novel human aldose reductase inhibitors based on a marine natural product.
    de la Fuente JA; Manzanaro S; Martín MJ; de Quesada TG; Reymundo I; Luengo SM; Gago F
    J Med Chem; 2003 Nov; 46(24):5208-21. PubMed ID: 14613323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of aldose reductase inhibition and docking studies of some secondary metabolites, isolated from Origanum vulgare L. ssp. hirtum.
    Koukoulitsa C; Zika C; Geromichalos GD; Demopoulos VJ; Skaltsa H
    Bioorg Med Chem; 2006 Mar; 14(5):1653-9. PubMed ID: 16249088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure-activity relations on [1-(3,5-difluoro-4-hydroxyphenyl)-1H-pyrrol-3-yl]phenylmethanone. The effect of methoxy substitution on aldose reductase inhibitory activity and selectivity.
    Chatzopoulou M; Mamadou E; Juskova M; Koukoulitsa C; Nicolaou I; Stefek M; Demopoulos VJ
    Bioorg Med Chem; 2011 Feb; 19(4):1426-33. PubMed ID: 21288726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discoveries in research on diabetic keratopathy.
    Cisarik-Fredenburg P
    Optometry; 2001 Nov; 72(11):691-704. PubMed ID: 12363257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and biological evaluation of [1,2,4]triazino[4,3-a] benzimidazole acetic acid derivatives as selective aldose reductase inhibitors.
    Sahoo PK; Behera P
    Eur J Med Chem; 2010 Mar; 45(3):909-14. PubMed ID: 19962793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.